Quantcast
Last updated on April 23, 2014 at 15:23 EDT

Latest estradiol Stories

2014-04-16 16:30:50

DUBLIN, April 16, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/q7jzmk/sustained_release) has announced the addition of the "Concise Analysis of International Sustained Release Injectables to 2020" [http://www.researchandmarkets.com/research/q7jzmk/sustained_release ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Formulations, Dosing, Devices, Markets and Forecasts The ability...

2014-03-24 16:24:14

MAPLE GROVE, Minn., March 24, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), a fully integrated pharmaceutical company committed to the development of new treatments for diseases of the central nervous system (CNS), today announced that it has entered into a definitive agreement under which New Jersey-based Vertical Pharmaceuticals, LLC has acquired Upsher-Smith's rights to Divigel(®) (estradiol gel) 0.1%, Nexa(®) Plus Rx Prenatal Vitamin, and Provella(®), a...

2014-03-24 16:24:09

Avista Capital Partners-Backed Company to Continue Add-On Acquisition Strategy SAYREVILLE, N.J., March 24, 2014 /PRNewswire/ -- Vertical Pharmaceuticals, LLC, a wholly owned subsidiary of Vertical / Trigen Holdings, LLC ("Vertical / Trigen"), today announced that it has acquired the rights to three branded women's health products from Upsher-Smith Laboratories, Inc. The terms of the transaction were not disclosed. Vertical / Trigen is a portfolio company of Avista Capital Partners....

2014-03-13 17:07:09

When initiated soon after menopause, hormone therapy with estradiol prevented degeneration in key brain regions of women who were at heightened dementia risk, according to a new study led by Stanford University School of Medicine researchers. The investigators also found that another type of hormone therapy, marketed under the brand name Premarin, was far less protective. Premarin is a mixture of 30-plus substances derived from the urine of pregnant mares. Estradiol — the dominant...

2014-02-11 08:25:00

DUBLIN, Feb. 11, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/5nldqw/sustained_release ) has announced the addition of the "Sustained Release Injectables to 2020" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Formulations, Dosing, Devices, Markets and Forecasts The ability to formulate injectable drugs to increase the duration of efficacy for a given dose and simultaneously reduce the dosing frequency...

2013-12-20 23:03:55

Alert: Drug Allegedly Linked to Serious Injuries and Deaths in Users DALLAS (PRWEB) December 20, 2013 The national plaintiffs’ law firm of Baron & Budd is now handling lawsuits on behalf of women who have used the contraceptive device NuvaRing, also known as the etonogestrel/ethinyl estradiol Vaginal Ring. Baron & Budd NuvaRing lawyers will represent women who allegedly suffered serious side effects or even died after using the birth control drug. The NuvaRing, produced by...

Researchers Discover Brain Actually Produces Estrogen Too
2013-12-05 10:53:07

April Flowers for redOrbit.com - Your Universe Online The brain can produce and release estrogen, according to a new study from the University of Wisconsin-Madison. This discovery could lead to a better understanding of hormonal changes observed from before birth throughout the entire aging process. The study findings, published in the Journal of Neuroscience, reveal that the hypothalamus can directly control reproductive function in rhesus macaques. The researchers suggest that the...

2013-11-22 23:20:59

New men’s and women’s formulations address imbalances at the source. Osceola, WI (PRWEB) November 22, 2013 NeuroScience, Inc., a national leader in personalized health solutions, has introduced three new products that address hormonal imbalances through support of the nervous system: AndroFlavone (for men) and FemFlavone (for women) provide support for healthy reproductive hormone levels. Containing D-aspartic acid and 7-methoxyflavone to prevent the conversion of testosterone to...

2013-11-12 08:34:06

Life Extension claims flawed testosterone analysis published in the Journal of the American Medical Association (JAMA) spurs misleading media headlines. FORT LAUDERDALE, Fla., Nov. 12, 2013 /PRNewswire/ -- The recent study, "Association of Testosterone Therapy With Mortality, Myocardial Infarction, and Stroke in Men With Low Testosterone Levels" published Nov. 5 in the Journal of the American Medical Association (JAMA), is flawed and will discourage aging men from properly restoring...

2013-11-08 08:27:22

The Journal of the American Medical Association misleading reports HOUSTON, Nov. 8, 2013 /PRNewswire/ -- The Journal of American Medical Association relayed that testosterone treatment may increase the risk of cardiovascular ailments. The basis of the study cautioned that men with pre-existing cardiovascular ailments might need to avoid testosterone. The holes in this study are so large it is beyond comprehension that any journalist or reporter could take the study seriously. It's...